Murdoch Childrens Research Institute
Browse

Clinical efficacy of single dose (daily) IV antibiotics followed by 2 days oral antibiotics compared to 3 doses (daily) IV antibiotics for children with complicated urinary tract infections: a multicentre randomised trial

Posted on 2024-12-27 - 00:59 authored by MCRI REDCap ServiceAccount
Complicated urinary tract infections are common reasons for hospital admissions and constitute a major burden for healthcare systems. However, research into the optimal treatment for children with urinary tract infections have only focused on those with an uncomplicated clinical course, neglecting those with a more complicated course. This trial aims to investigate the optimal treatment for this group, single dose IV plus 2 days oral antibiotics or 3 days of IV antibiotics. Patients are aged 3 months to 18 years who have presented to the ED with a UTI and ≥3 complicated features (history of recurrent UTI, urological abnormalities, fever, vomiting, rigors and tachycardia) are eligible.
Methods: Randomisation to receive single dose of intravenous antibiotics (and 2days oral antibiotics) or 3 days of IV antibiotics. At 72 hours after initial IV dose, clinical failure is defined as persistence of baseline symptoms (fever or vomiting or rigors) or development of new symptoms (fever or vomiting or rigors) attributed to UTI.
Expected outcomes:Proportion of children with clinical failure is similar in both groups. Children with UTI will only need a single dose IV and rapidly switch to oral antibiotics.

CITE THIS COLLECTION

DataCite
3 Biotech
3D Printing in Medicine
3D Research
3D-Printed Materials and Systems
4OR
AAPG Bulletin
AAPS Open
AAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)
Academic Medicine
Academic Pediatrics
Academic Psychiatry
Academic Questions
Academy of Management Discoveries
Academy of Management Journal
Academy of Management Learning and Education
Academy of Management Perspectives
Academy of Management Proceedings
Academy of Management Review
or
Select your citation style and then place your mouse over the citation text to select it.

Project Identifier

72065

Data Steward

emily.mckie

Data Controller

laila.ibrahim

HREC Number

72065

Data Retention

Retention period: 15; Destruction plan: Data will be kept for at least 15 years after the completion of a clinical trial in accordance with the requirements of the Therapeutic Goods Administration or until the 25th birthday of the youngest participant (Victorian Health Records Act 2001) (whichever is the later date).

Storage Location(s)

Long-term storage location(s): HS - Florence eBinders (Clinical Trials only), HS - MCRI OneDrive, HS - MCRI SharePoint / Intranet, HS - REDCap; Network folder:

SHARE

email
need help?